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Abstract  22 
Objectives To estimate prevalence of post-colposcopy physical after-effects and investigate 23 
associations between these and subsequent psychological distress. 24 
Design Longitudinal survey. 25 
Setting Two hospital-based colposcopy clinics. 26 
Population Women with abnormal cytology who underwent colposcopy (+/- related 27 
procedures). 28 
Methods Questionnaires were mailed to women 4-, 8- and 12-months post-colposcopy. Details 29 
of physical after-effects (pain, bleeding and discharge) experienced post-colposcopy were 30 
collected at 4-months. Colposcopy-specific distress was measured using the Process Outcome 31 
Specific Measure at all time-points. Linear mixed effects regression was used to identify 32 
associations between physical after-effects and distress over 12-months, adjusting for socio-33 
demographic and clinical variables. 34 
Main outcome measures Prevalence of post-colposcopy physical after-effects. Associations 35 
between presence of any physical after-effects, awareness of after-effects and number of after-36 
effects and distress. 37 
Results 584 women were recruited (response rate=73%, 59% and 52% at 4, 8 and 12-months, 38 
respectively). 82% of women reported one or more physical after-effect(s). Multiple physical 39 
after-effects were common (two after-effects=25%; three after-effects=25%). Psychological 40 
distress scores declined significantly over time. In adjusted analyses, women who experienced all 41 
three physical after-effects had on average a 4.58 (95% CI 1.10 to 8.05) higher distress scored 42 
than those who experienced no after-effects. Women who were unaware of the possibility of 43 
experiencing after-effects scored significantly higher for distress during follow-up. 44 
Conclusions Prevalence of physical after-effects of colposcopy and related procedures is high. 45 
The novel findings of inter-relationships between awareness of the possibility of after-effects, 46 
and experiencing multiple after-effects, and post-colposcopy distress may be relevant to the 47 
development of interventions to alleviate post-colposcopy distress. 48 
 49 
Keywords Longitudinal survey, colposcopy, post-colposcopy distress, physical after-effects. 50 
 51 
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Tweetable abstract Experiencing multiple physical after-effects of colposcopy is associated 52 
with psychological distress. 53 
54 
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Introduction 55 
For cervical screening to be effective, women who have a positive screening test (irrespective of 56 
whether the initial test is cytological- or HPV-based) require follow-up. Hospital-based 57 
colposcopy examinations are a cornerstone of follow-up and likely to remain so under the newer 58 
screening protocols. Colposcopy is a very common procedure; for example, each year almost 59 
200,000 women in England and 16,000 in Ireland are referred for colposcopy.1,2  60 
Undergoing colposcopy and related treatment procedures (e.g. large loop excision of the 61 
transformation zone (LLETZ)) can be distressing and studies have shown that women may have 62 
raised anxiety levels prior to, during, and after a colposcopy.3-7  While there is considerable 63 
evidence for psychological morbidity among women undergoing colposcopy, data on post-64 
colposcopy physical after-effects (e.g. pain or bleeding) reported by women is relatively scarce. 65 
Nonetheless, the data that is available suggests that high proportions of women experience 66 
physical after-effects. For example, in a study of 108 women, 68% reported experiencing pain 67 
after a LLETZ,8 while in another study of 751 women, 79% of those who had punch biopsies, 68 
and 87% of those who  had a LLETZ, reported bleeding afterwards.9  Emerging findings 69 
tentatively suggest that the physical and psychological consequences of colposcopy and related 70 
procedures may be linked. In recent qualitative work among women who had had colposcopy 71 
and/or related procedures, we found that having had physical after-effects that impacted on their 72 
lives was related to women experiencing long-term psychological distress.10 Similarly, a 73 
quantitative study found that women who reported pain or bleeding post-colposcopy had 74 
increased risk of psychological distress,6 but that study was cross-sectional so the direction of the 75 
association was uncertain.  76 
In a 12-month longitudinal study of women attending colposcopy, we investigated prevalence of 77 
physical after-effects following colposcopy and related procedures and associations between 78 
experiencing physical after-effects and subsequent psychological distress. We further 79 
investigated whether women’s awareness of the possibility of physical after-effects was related 80 
to subsequent distress. 81 
  82 
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Methods 83 
Setting 84 
The study was conducted in Ireland, which has a mixed public-private healthcare system. 85 
CervicalCheck, the national cervical screening programme was implemented in 2008, offering 86 
free cervical cytology tests and follow-up, if required, to women aged 25-60 years. Women with 87 
two or more low-grade abnormal cervical cytology test results, or one high-grade result, are 88 
referred for colposcopy in a clinic affiliated with the screening programme located in one of 15 89 
maternity hospitals throughout Ireland.1  90 
Study participants and recruitment 91 
Women who attended CervicalCheck colposcopy clinics at two large Dublin hospitals were 92 
recruited to the study between September 2010 and July 2011. To be eligible, women had to 93 
have been referred to colposcopy on the basis of an abnormal cervical cytology test result, in the 94 
context of routine screening. They were eligible irrespective of the management they received at 95 
their initial clinic appointment (i.e. colposcopy only, punch biopsies, loop excision, or another 96 
form of intervention or treatment) or subsequent follow-up. Women who had previously had 97 
treatment for cervical abnormalities, or who were pregnant at the time of recruitment (i.e. at the 98 
initial colposcopy clinic appointment) were ineligible.  At their clinic appointment, women were 99 
invited to take part in the study by research staff and were given a study information sheet. 100 
Women willing to participate in the study signed a consent form and returned it to research staff. 101 
Consenting women were invited to complete a questionnaire which was sent by post at 4, 8 and 102 
12 months following their initial colposcopy appointment.  103 
Ethical approval was obtained from the ethics committees of the Coombe Women and Infants 104 
University Hospital and the National Maternity Hospital, Dublin. 105 
  106 
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Assessment of physical after-effects of colposcopy and related procedures 107 
Physical after-effects were assessed at 4 month follow-up using a questionnaire designed to 108 
measure three physical after-effects of colposcopy and related procedures - pain, bleeding and 109 
discharge- developed in the UK TOMBOLA trial.9 Women were also asked whether they had 110 
been aware that they might experience physical after-effects. Table S1 displays the questions 111 
asked and response options. 112 
 113 
Assessment of post-colposcopy psychological distress 114 
Psychological distress was measured at three time points: 4, 8 and 12 months post-colposcopy. It 115 
was assessed using the Process Outcome Specific Measure (POSM), which was developed 116 
specifically to evaluate issues of concern to women being followed-up for abnormal cervical 117 
cytology.11 The POSM contains 14 items, 7 of which can be combined into a measure of distress 118 
(Table S2;12). Six of these seven items have six-level Likert response options ranging from 119 
‘Strongly agree’ to’ Strongly disagree’. The remaining item has seven response options ranging 120 
from ‘Strongly for the better’ to ‘Strongly for the worse’. Women were asked to indicate the 121 
extent to which each statement applied ‘in the last month’. The raw score for each of the seven 122 
questions was multiplied by 100 and divided by the maximum possible raw score for that 123 
question. Item responses for each question were thus standardised to be scored out of 100. The 124 
overall distress score was obtained by calculating the arithmetic mean of the seven standardised 125 
item scores. The higher the overall score, the greater the psychological distress/burden.  126 
Co-variates 127 
Information on potential confounders of the relationship between physical after-effects and 128 
psychological distress was obtained from the questionnaire administered at the 4 month time-129 
point and from women’s clinic records. Questions on socio-demographic characteristics, lifestyle 130 
behaviours and attitudes, and healthcare-related history were included in the questionnaire. Data 131 
extracted from clinic records were: colposcopy referral cytology, initial colposcopic impression, 132 
initial management received and initial histology result. Table 1 and Table S3 list the co-variates 133 
available. 134 
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Statistical analyses 135 
Stata (version 13) was used for analysis. Characteristics of respondents were summarised using 136 
descriptive statistics.  Summary statistics for any, number of, and each type of, physical after-137 
effect were calculated. T-tests were used to determine if the distress score at each time point 138 
differed between: (i) those with any versus no after-effects; and (ii) those with and without each 139 
type of after-effect. Similarly, summary statistics and t-tests were also computed for awareness 140 
of the possibility of physical after-effects. At each follow-up time point, a test for trend was 141 
calculated to assess if the distress score increased with increasing number of physical after-142 
effects.  143 
Since our primary aim was to determine whether presence of any physical after-effects (and/or 144 
awareness of after-effects) was associated with psychological distress, we created a binary 145 
variable which was 0 if no physical after-effects were experienced and 1 if one or more (of 146 
pain/bleeding/discharge) was experienced. In order to account for the longitudinal nature of the 147 
outcome psychological distress, we employed a linear mixed effects model, with unstructured 148 
covariance. This allowed women who have a distress score at least one follow-up time-point to 149 
be included in the analysis, with any missing data assumed to be missing at random. Initially, 150 
fixed effects for follow-up time and experience of physical after-effect(s) were included in the 151 
model. To investigate whether there were differences in the pattern of distress over time between 152 
those with and without any after-effects, an interaction between follow-up time and the binary 153 
physical after-effects variable was tested.  We then included the variable awareness of physical 154 
after-effects and also tested for an interaction between follow-up time and awareness of physical 155 
after-effects.  156 
In order to choose the final multivariable model, we started with a saturated model consisting of 157 
the physical after-effect (any/none) variable and all candidate co-variates. Using a stepwise 158 
backward approach we eliminated variables if the p-value for inclusion was greater than 0.1 159 
(Wald test), taking care to avoid multicollinearity between co-variates. The main explanatory 160 
variable – any physical after-effects - was kept in the model regardless of its p-value. As a check 161 
of the model, we fitted models with random intercepts only and random intercepts and slopes; we 162 
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concluded that these more complex models were not required and have reported the findings 163 
from the final fixed effects multivariable model. 164 
To determine whether number of physical after-effects predicted distress, we ran a multivariable 165 
model in a similar manner replacing the binary physical after-effects variable with a 4-level 166 
variable representing the number of physical after-effects experienced. As above we checked 167 
whether the variable awareness of after effects should be included in this model.  168 
To explore whether the association between physical after-effects and distress varied by type of 169 
physical after-effect, we conducted a sensitivity analysis in which we re-ran the final 170 
multivariable model three times, each time replacing the any physical after-effects variable with 171 
a binary variable representing any pain or bleeding or discharge.  As above we checked whether 172 
the variable awareness of after effects should be included in this model. We did not fit these 173 
three different after-effects simultaneously as they were highly correlated. 174 
Results  175 
Characteristics of respondents 176 
429 of the 584 women recruited to the study completed the 4 month questionnaire (73%), 343 177 
(59%) completed the questionnaire at 8 months; and 303 (52%) completed the questionnaire at 178 
12 months. Table 1 displays  selected socio-demographic characteristics and clinical variables 179 
for the 429 who completed the 4-month questionnaire. The additional socio-demographic, 180 
lifestyle behaviours and attitudes, and health-care related history variables are displayed in Table 181 
S3. 182 
 183 
Prevalence of physical after-effects 184 
Overall, 82% of women experienced at least one physical after-effect, with a quarter (25%) 185 
experiencing all three physical after-effects (Figure 1). In terms of individual after-effects, 68% 186 
reported experiencing bleeding, 58% experienced pain, and 39% experienced discharge. The 187 
majority (86%) of respondents were aware of the possibility of having after-effects following 188 
their colposcopy.  189 
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Unadjusted associations between physical after-effects and post-colposcopy psychological 190 
distress, by follow-up time point 191 
The mean distress score at 4 months was 46.6 (of a possible 100), reducing by approximately 2 192 
points at each subsequent follow-up time point (Table 2). The distress score was significantly 193 
higher for those with at least one physical after effect (v. none) at each time point. This result 194 
was mirrored for each of the individual after-effects, pain, bleeding and discharge (Table 2). At 195 
each time point, there was a statistically significant trend of higher distress with increasing 196 
number of after-effects (p≤0.001).  197 
At all three time points, women who were not aware of the possibility of physical side-effects 198 
had higher distress scores than women aware of this possibility; this difference was statistically 199 
significant at the 4 and 8 month time points.  200 
Regression results 201 
Any physical after-effects 202 
In the multivariable analysis with any vs. no physical after-effects as the main explanatory 203 
variable of interest, having any physical after-effect was associated with a higher distress score 204 
over the entire follow-up period (2.11; 95% CI -0.76 to 4.97; Table 3; with full multivariable 205 
results shown in Table S4), but this was not statistically significant (Wald test p-value 0.15; 206 
Table 3). In the same model, not being aware of the possibility of physical after-effects was 207 
significantly associated with higher distress score (on average 3.99 points higher) during follow-208 
up (Wald test p-value 0.02; Table 3). 209 
There was no significant interaction between distress score and whether or not a physical after-210 
effect (any vs. none) was experienced over the follow-up period. In addition, there was no 211 
evidence of an interaction between awareness of physical after-effects and distress score over 212 
time. 213 
Number of physical after-effects 214 
In the multivariable analysis, number of physical after-effects was significantly associated with a 215 
higher distress score during follow-up (Wald test p-value 0.03, Table 3).There was also a 216 
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significant linear trend (p=0.004).  In women with two physical after-effects, follow-up related 217 
distress was on average 2.20 (95% CI -0.97 to 5.38) points higher than for women who 218 
experienced none (Table 3); follow-up related distress was on average 4.58 (95% CI 1.10 to 219 
8.05) points higher in women who experienced all three physical after-effects than in women 220 
who experienced none (Table 3).  In a linear test for trend, a one unit increase in the number of 221 
physical after effects was associated with a 1.6 increase in psychological distress score, p = 222 
0.004. Not being aware of the possibility of physical after-effects was significantly associated 223 
with on average a 4.25 (95% CI 0.93 to 7.57) higher distress score (Wald test p-value 0.01). 224 
Sensitivity analysis: type of physical after-effect 225 
In our sensitivity analysis, the effect size for association with (a higher) distress score was 226 
similar for each physical after-effect. In women who experienced pain, follow-up related distress 227 
was on average 2.32 (95% CI 0.01 to 4.62) points higher than for women who experienced none. 228 
Follow-up related distress was on average 2.40 (95% CI -0.06 to 4.86) points higher in women 229 
who experienced bleeding than in women who experienced none and was 2.30 (95% 0.02 to 230 
4.57) points on average higher in women who experienced distress than in women who 231 
experienced no discharge (Table 3). 232 
  233 
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Discussion  234 
Main findings 235 
Our study has highlighted the burden of physical after-effects of colposcopy/treatment on 236 
women. The prevalence of physical after-effects following these types of procedures is high; four 237 
in every five women reported experiencing one or more after-effect. We also found, in 238 
longitudinal analyses, associations between physical after-effects and psychological distress 239 
following colposcopy. While there was no statistically significant difference in distress between 240 
women who experienced any physical after-effect and those who experienced none - over the 241 
entire 12 month follow-up period, women who experienced all three physical after-effects had 242 
significantly higher distress levels than women who did not (after adjusting for covariates). In 243 
addition having no awareness of the possibility of physical after-effects was significantly related 244 
to higher distress post-colposcopy in unadjusted and adjusted analyses. 245 
Strengths and limitations 246 
The major strengths of this study were the longitudinal design and the fact it was nested in 247 
clinics affiliated with the screening programme, so reflects real-world clinical practice. In terms 248 
of possible limitations, physical after-effects were measured at 4 months post-colposcopy and 249 
there may be some inaccuracy in recall. While we found increased distress in women with 250 
multiple after-effects, we did not have sufficiently large sample size to be able to identify 251 
whether any particular combinations of after-effects were responsible for the association. While 252 
we found statistically significant differences in the average POSM scores at each time point, 253 
further work is needed to determine whether these differences would represent a clinically 254 
meaningful difference in psychosocial wellbeing. We do not know the characteristics of non-255 
responders (those who consented to taking part but did not respond to questionnaires). Therefore, 256 
we cannot exclude the possibility that responders and non-responders differed in terms of socio-257 
demographic characteristics, physical after-effects or distress. Among women who responded to 258 
the 4-month questionnaire, those who also responded at 12-months had a lower mean distress 259 
score than women who did not respond at 12-months; this suggests that women who dropped out 260 
of the study were more likely to be distressed and that we may have under-estimated the true 261 
mean distress score Although women in our study would have received information leaflets 262 
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which contained some (limited) information about possible after-effects, we do not know 263 
anything about the verbal information clinic staff may have given women during their 264 
consultations about the possibility of experiencing physical after-effects, and whether/how this 265 
might have impacted on experiences.  266 
Interpretation 267 
The high proportions of women experiencing physical after-effects in our study are a cause for 268 
concern. Other evidence on the burden of physical after-effects of colposcopy and related 269 
procedures is scarce with most studies conducted more than 10 years ago and focused mainly on 270 
after-effects of LLETZ.13-15 In these studies, LLETZ appears to be strong a predictor a greater 271 
physical after-effect burden. In the current study, only 18% of women underwent LLETZ 272 
treatments, yet the percentages of women overall who reported bleeding and pain was 70% and 273 
60%, respectively. These figures are much higher than those reported (using the same 274 
instrument) in the TOMBOLA trial (pain 37%, bleeding 46%).9 This may be due to the fact that, 275 
in the current study, approximately 75% of women were managed by colposcopy with punch 276 
biopsies or treatment compared to less than half (46%) of the women in TOMBOLA. In recent 277 
years the proportion of women with an abnormal transformation zone who have undergone 278 
diagnostic biopsies at colposcopy clinics in Ireland has increased steadily from 87.8% in 279 
2010/201116  to 95.4% in 2014/2015.1 The high proportions of physical after-effects observed in 280 
our study suggests that diagnostic biopsies can incur significant physical-after-effects for women 281 
and this needs to be considered when managing women referred to colposcopy.  282 
Our study also found, for the first time in a longitudinal analysis, that there is a positive 283 
association between number of physical-after-effects experienced and post-colposcopy distress. 284 
Similar findings have been reported in studies of other health-related conditions. In one follow-285 
up study among women with recurrent breast cancer, those who experienced multiple symptoms 286 
were at increased risk of distress.17 In another study among women who had completed breast 287 
cancer treatment, greater physical side-effects predicted greater distress. 18 It may be that having 288 
one side-effect of cancer treatment (or any procedure) is anticipated by individuals and perceived 289 
as normal but worry, and hence distress, intensifies when multiple after-effects are experienced. 290 
Another explanation may relate to the representations women hold of their ‘condition’ (abnormal 291 
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cervical cytology) and their management experiences.19 Women in our study who perceived their 292 
multiple physical after-effects as serious may have been more likely to be worried about them 293 
(and therefore have post-colposcopy distress) than those who did not have multiple physical 294 
after-effects –this is somewhat alluded to in a study of women who were treated for breast 295 
cancer, In that study, patients who viewed their illness as having serious consequences reported 296 
worse physical and mental health than those who did not .20 Interestingly, the magnitude of the 297 
association between physical after-effects and distress in our study was similar, irrespective of 298 
the type of physical after-effect experienced. Our findings suggest more emphasis on the 299 
possibility of experiencing multiple physical after-effects in pre-colposcopy and post-colposcopy 300 
counselling may be required to minimise distress. 301 
We have shown in a recent qualitative study that some women can have negative sensory 343 
experiences of colposcopy and related procedures (which can lead to post-colposcopy distress) 344 
and that factors contributing to women having a negative sensory procedure included sensory 345 
expectations of the procedure(s) and lack of preparatory sensory information (i.e. how the 346 
procedures may feel).10 Similar to this, in the current study women who were unaware of the 347 
possibility of experiencing physical after-effects had greater post-colposcopy distress during 348 
follow-up than women who were aware they could experience some physical after-effects. 349 
Physical after-effects of procedures such as colposcopy, punch biopsies, and LLETZ are for the 350 
main part unavoidable. However, increasing awareness that such side-effects can occur is in 351 
principle, modifiable and raising women’s awareness that physical after-effects are common and 352 
“normal” may serve to ameliorate post-colposcopy psychological wellbeing.  353 
Our findings highlight the importance of preparing women for the possibility of experiencing 354 
(perhaps multiple) physical after-effects through counselling pre-colposcopy and the provision of 355 
appropriate procedure-related information on physical after-effects (e.g. via screening 356 
programme information materials). The novel findings of inter-relationships between awareness 357 
of the possibility of after-effects and experiencing multiple physical after-effects, and post-358 
colposcopy distress may be relevant to the development of interventions to ease post-colposcopy 359 
distress. In particular, our findings highlight that, among women who experience multiple 360 
physical after-effects, targeted intervention measures to alleviate post-colposcopy distress are 361 
needed. 362 
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Conclusion 363 
The prevalence of physical after-effects of colposcopy and related procedures is high. Our 364 
findings of inter-relationships between awareness of the possibility of after-effects, and 365 
experiencing multiple physical after-effects, and post-colposcopy distress may be useful for the 366 
development and targeting of interventions to alleviate post-colposcopy distress. 367 
 368 
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Table 1. Selected socio-demographic characteristics and clinical variables* 
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Total 
 
 n % 
Age  
 < 30 years 153 36.0 
 30 – 40 years 146 34.4 
 > 40 years 126 29.6 
 Not stated 4  
Highest level of education attained  
 Third level (e.g. college, university) 286 67.5 
 Primary/secondary 138 32.5 
 Not stated 5  
Marital status  
 Married/cohabiting 199 46.7 
 Divorced/separated/widowed 36 8.5 
 Single 191 44.8 
 Not stated 3  
Have children  
 Yes 215 50.6 
 No 210 49.4 
 Not stated 4  
Private health insurance  
 Yes 207 48.4 
 No 221 51.6 
 Not stated 1  
Referral cytology test result  
 Low grade (borderline/mild) 329 76.7 
 High grade (moderate/severe) 95 22.1 
 Not available 5 1.2 
Colposcopic impression  
 Normal 114 26.6 
 Abnormal 293 68.3 
 Unsatisfactory 8 1.9 
 Not available 14 3.3 
Initial management received  
 Colposcopy only 110 25.8 
 Colposcopy plus punch biopsies** 241 56.4 
 Colposcopy plus LLETZ*** 76 17.8 
 Not available 2  
Histology result at/following initial colposcopy  
 No CIN  65 15.2 
 CIN 1 90 21.0 
 CIN 2+ 145 33.8 
 No result/result unavailable/colposcopy unsatisfactory 129 30.1 
*Measured at 4 months post-colposcopy; **Women had 1 or more biopsies taken with their colposcopy, with further procedures 
dependant on biopsy findings;***Women had colposcopy and were managed by immediate treatment (LLETZ; Large Loop Excision 
of the Transformation Zone) 
 
 
Table 2. Prevalence of physical after-effects (number (%)), mean distress scores (with standard deviations (SD)) and p 
values for associations between physical after-effects and distress at 4, 8 and 12 months post-colposcopy 
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Total 
 
Sample characteristics 
at 4 months 
Number (%)  
 
Mean (SD) 
distress 
score at 4 
months 
(n =402) 
Mean (SD) 
distress 
score at 8 
months 
(n = 331) 
Mean (SD) 
distress 
score at 12 
months 
(n = 294) 
 
Overall distress       
Whole sample 402 (100%) 46.6 (14.7)  44.2 (13.5)      42.2 (13.9) 
Any physical after-effect     
Yes 324 (82%) 47.4 (14.7) 44.8 (13.7) 43.2 (13.8) 
No 73 (18%) 43.0 (14.1) 39.5 (12.5 37.6 (12.6) 
p value*  0.019 0.005 0.006 
Number of physical after-effects   
0 73 (18%) 43.0 (14.1) 39.5 (12.5) 37.6 (12.6) 
1 81 (20%) 44.5 (13.6) 41.4 (14.6) 39.7 (13.1) 
2 140 (35% ) 46.8 (14.4) 44.7 (12.7) 42.7 (12.7) 
3 103 (26%) 50.5 (15.4) 47.8 (13.8) 47.3 (15.2) 
p-value**  0.001 <0.001 <0.001 
Pain     
Yes 248 (59%) 48.1 (15.0) 45.8 (13.4) 44.2 (13.9) 
No 173 (41%) 44.4 (13.9) 40.9 (13.5) 39.5 (12.9) 
p value*  0.012 0.002 0.004 
Bleeding     
Yes 290 (69%) 47.7 (14.4) 45.1 (13.2) 43.6 (13.6) 
No 132 (31%) 43.8 (14.8) 40.5 (14.1) 38.8 (13.2) 
p value *  0.012 0.006 0.003 
Discharge     
Yes 167 (40%) 49.2 (15.6) 46.6 (14.5) 45.5 (15.1) 
No 253 (60%) 44.9 (13.8) 42.0 (12.8) 40.3 (12.7) 
p value *  0.004 0.004 0.003 
Awareness of the possibility of experiencing after-effects    
Yes 370 (86%) 46.0 (14.4) 43.1 (13.1) 41.6 (13.6) 
No 55 (13%) 50.8 (16.2) 48.7 (16.4)   45.1 (13.9) 
p value *  0.033 0.014 0.173 
*t-test, **test for trend. 
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Table 3. Multivariable mixed effects model results for associations between after-effects and distress and sensitivity 
analysis results (to test whether distress varied by type of physical after-effect –pain, bleeding or discharge) 
  Distress score* 
 Adjusted mean** Estimate 95% CI p value*** 
Any physical after-effects     
None 42.7 (40.2, 45.2) Ref   
Any (vs none) 44.8 (43.6, 46.0) 2.11 (-0.76, 4.97) 0.149 
Number of physical after-effects****     
0 42.5 (40.0, 45.0) Ref   
1 42.8 (40.5, 45.1) 0.32 (-3.05, 3.68)  
2 44.7 (42.8, 46.5) 2.20 (-0.97, 5.38)  
3 47.0 (44.8, 49.2) 4.58 (1.10, 8.05) 0.030 
Pain     
No 
Yes 
43.1 (41.4, 44.8) Ref   
45.4 (43.9, 46.8) 2.32 (0.01, 4.62) 0.049 
Bleeding     
No 
Yes 
42.8 (40.8, 44.7) Ref   
45.2 (43.8, 46.4) 2.40 (-0.06, 4.86) 0.056 
Discharge     
No 
Yes 
43.5 (42.2, 44.9) Ref   
45.8 (44.0, 47.6) 2.30 (0.02, 4.57) 0.048 
Awareness of the possibility of experiencing 
after-effects***** 
    
Yes 43.9 (42.8, 45.0) Ref   
No 47.9 (44.8, 51.0) 4.00 (0.66, 7.32) 0.019 
* All models adjusted for timepoint, awareness of possibility of physical after-effects, initial colposcopy histology result, age, 
smoking status, perceived severity of colposcopy exam, satisfaction with healthcare and whether or not the woman had had 
colposcopy prior to taking part in the current study. **Predicted margins with 95% confidence interval, from multivariable models. 
***Wald test p-values. ****The test for linear trend was significant (p=0.004). *****Estimate from the primary model, with main 
variable of interest physical after effects (any v. none).   
 
 
 
 
 
 
 
 
 
  
22 
 
Figure 1. Percentages of women with none, one, two or three after-effects*  
  
 
*Of 429 women, physical after-effects assessed in the 4-month questionnaire only. 
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Table S1. Questions (and response options) on physical after-effects of colposcopy and related procedures measured 4 
months following women’s initial colposcopy 
1a. Did you have any discomfort/pain following your appointment? 
                     Yes 1                  No 2   
     If No, please go to question 2a   
         
 (1b) If Yes, How long did the discomfort/pain last?   
       DAYS   
         
 (1c) If Yes, At its worst, was your discomfort/pain?   
 Very mild Mild Moderate Severe Very severe 
      
 1 2 3 4 5 
         
2a. Did you have any bleeding following your appointment? 
                      Yes 1                   No 2   
     If No, please go to question 3a   
 (2b) If Yes, How long did the bleeding last?     
       DAYS   
         
 (2c) If Yes, At its worst, was your bleeding?     
 Very light 
(spotting) 
Light Moderate Heavy Very heavy 
 1 2 3 4 5 
         
3a. Did you have any unpleasant discharge following your appointment? 
                       Yes 1                    No 2   
     If No, please go to question 4   
         
 (3b) If Yes, How long did the discharge last?     
       DAYS   
         
 (3c) If Yes, At its worst, was your discharge?     
 Very light Light Moderate Heavy Very heavy 
 1 2 3 4 5 
         
4. Were you aware that you might have some after-effects following your appointment? 
                       Yes 1                   No 2   
         
5. Overall were your after-effects? 
 I didn’t have any  
after-effects 
Same as I expected Worse than I expected Not as bad as I 
expected 
 1 2 3 4 
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Table S2. POSM items used to develop an overall POSM score 
POSM item* (abbreviated)  Response options 
Feel well enough informed about my follow-
up 
Strongly 
agree 
Moderately 
agree 
Slightly 
agree 
Slightly 
disagree 
Moderately 
disagree 
Strongly 
disagree 
       
Worried about my general health Strongly 
agree 
Moderately 
agree 
Slightly 
agree 
Slightly 
disagree 
Moderately 
disagree 
Strongly 
disagree 
       
Way I feel about myself has changed Strongly for 
the better 
Moderately 
for the  
better 
Slightly 
for the 
better 
Neither for the 
better nor worse 
Slightly 
for the 
worse 
Moderately 
for the 
worse 
Strongly for 
the worse 
        
Worried that my next smear will show 
changes to the cells 
Strongly 
agree 
Moderately 
agree 
Slightly 
agree 
Slightly 
disagree 
Moderately 
disagree 
Strongly 
disagree 
       
Worried that I may have cervical cancer Strongly 
agree 
Moderately 
agree 
Slightly 
agree 
Slightly 
disagree 
Moderately 
disagree 
Strongly 
disagree 
       
Worried about having sex Strongly 
agree 
Moderately 
agree 
Slightly 
agree 
Slightly 
disagree 
Moderately 
disagree 
Strongly 
disagree 
       
Satisfied with support I have had from other 
people 
Strongly 
agree 
Moderately 
agree 
Slightly 
agree 
Slightly 
disagree 
Moderately 
disagree 
Strongly 
disagree 
POSM, Process Outcome Specific Measure 
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Table S3. Socio-demographic characteristics (continued), lifestyle behaviours and attitudes, and 
health-care related history* 
Total 
 
 n % 
Employment status  
 In work (working for an employer or self-employed) 306 71.7 
 Other**  121 28.3 
 Not stated 2  
Nationality  
 Irish 386 90.8 
 Other 39 9.2 
 Not stated 4  
Currently pregnant  
 Yes*** 17 4.0 
 No 410 96.0 
 Not stated 2  
Smoking status  
 Current smoker  140 32.8 
 Never smoked 153 35.8 
 Past smoker 134 31.4 
 Not stated 2  
History of depression****  
 Yes 123 28.9 
 No 303 71.1 
 Not stated 3  
Social support: No. of close friends and relatives  
 Mean 7.4 (5.7) - 
Satisfaction with life  
 Mean (SD) satisfaction with life 7.3 (1.8)***** - 
Satisfaction with healthcare  
 Mean (SD) satisfaction with healthcare 5.0 (1.1)1 - 
Ever had an abnormal cervical cytology test result2  
 Yes 247 58.3 
 No 177 41.7 
 Not stated 5  
Ever had a colposcopy examination3  
 Yes 89 20.8 
 No 339 79.2 
 Not stated 1  
Perceived severity of a colposcopy exam  
 Not at all serious 25 5.9 
 Slightly serious 210 49.2 
 Serious 149 34.9 
 Very serious 43 10.1 
 Not stated 2  
*Measured at 4 months post-colposcopy;**Unemployed, retired from employment, unable to work, looking 
after family/home or student; *** women who were pregnant at the time of the 4-month questionnaire but not 
pregnant at recruitment (the initial colposcopy appointment);****Self-reported depression;*****mean is from 
possible Likert score of 1-10; 1mean is from possible Likert score of 1-7; 2Prior to the one the woman had at 
study recruitment; 3Prior to taking part in the study  
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Table S4. Multivariable mixed effects model for association between distress score and experiencing none v any physical after-effects 
  Distress score 
 Adjusted mean* Estimate 95% CI p value** 
Any physical after-effects     
None 42.7 (40.2, 45.2) Ref   
Any (v none) 44.8 (43.6, 46.0) 2.11 (-0.76, 4.97) 0.149 
Awareness of physical after-effects     
Yes 43.9 (42.8, 45.0) Ref   
No 47.9 (44.7, 51.0) 3.99 (0.66, 7.32) 0.019 
Timepoint 45.8 (44.5, 47.0) -1.60 (-2.34, -0.85) <0.001 
Initial Colposcopy Histology result     
No CIN 41.9 (39.1, 44.6) Ref   
CIN 1 44.7 (42.4, 47.1) 2.89 (-0.69, 6.48)  
CIN 2+ 47.5 (45.5, 49.5) 5.65 ( 2.26, 9.04)  
No result/result unavailable/colposcopy unsatisfactory 42.0 (40.0, 44.1) 0.17 (-3.23, 3.58) <0.001 
Perceived severity of colposcopy exam     
Not serious 35.6 (31.1, 40.2) Ref   
Slightly serious 42.5 (41.0, 44.0) 6.89 (2.08, 11.69)  
Serious 46.7 (44.9, 48.5) 11.10 (6.17, 16.02)  
Very serious 50.8 (47.3, 54.2) 15.16 (9.37, 20.95) <0.001 
Ever had a colposcopy***     
Yes 43.5 (42.3, 44.7) Ref   
No 47.9 (45.6, 50.3) -4.45 (-7.13, -1.76) 0.001 
Satisfaction with healthcare     
Per unit increase**** 44.4 (43.4, 45.5) -2.46 (-3.49, -1.44) <0.001 
Smoking status     
Current smoker 46.5 (44.5, 48.4) Ref   
Never smoked 44.9 (43.1, 46.7) -1.51 (-4.21, 1.19)  
Past smoker 41.8 (39.9, 43.7) -4.70 (-7.46, -1.95) 0.003 
Age     
< 30 years 47.1 (45.3, 48.9) Ref   
30 - 40 years 44.1 (42.3, 45.9) -3.01 (-5.58, -0.45)  
≥ 40 years 41.8 (39.8, 43.7) -5.35 (-8.03, -2.67) <0.001 
*predicted margins with 95% confidence intervals, from multivariable models;**Wald test p value; ***Prior to the one the woman had at study  
recruitment; ****Likert scale range 1-7; Completely satisfied = 7.  
 
 
